Clinical Trials Directory

Trials / Completed

CompletedNCT05995561

HERA FIb Registry for Patients With Atrial Fibrillation

Heidelberg Registry of Atrial Fibrillation

Status
Completed
Phase
Study type
Observational
Enrollment
12,297 (actual)
Sponsor
University Hospital Heidelberg · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The single-center HERA AFIb registry was created to assess real-world prevalence, demographic characteristics and management of patients with atrial fibrillation (AF) in the era of novel oral anticoagulant regimes (NOAC) presenting in the emergency department (ED) of University of Heidelberg

Detailed description

HERA AFIb is a single-center retrospective registry which enrolled consecutive cases presenting with atrial fibrillation at the emergency department of University Hospital of Heidelberg. Clinical parameters and characteristics for cases were assessed retrospectively. Follow-up was performed via review of medical reports, phone calls and postal queries. Outcome parameters included rates for all-cause mortality, non-hemorrhagic stroke, myocardial infarction and major bleeding.

Conditions

Interventions

TypeNameDescription
OTHERno intervention is planned.no intervention is planned.

Timeline

Start date
2009-06-01
Primary completion
2020-04-01
Completion
2020-04-01
First posted
2023-08-16
Last updated
2024-05-09

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05995561. Inclusion in this directory is not an endorsement.